Cinemark (NYSE:CNK – Get Free Report) is expected to post its Q4 2025 results before the market opens on Wednesday, February 18th. Analysts expect Cinemark to post earnings of $0.45 per share and revenue of $778.4140 million for the quarter. Parties may visit the the company’s upcoming Q4 2025 earning results page for the latest details on the call scheduled for Wednesday, February 18, 2026 at 8:30 AM ET.
Cinemark Stock Down 0.1%
Shares of Cinemark stock opened at $25.79 on Wednesday. Cinemark has a 1 year low of $21.60 and a 1 year high of $34.01. The company has a market cap of $3.03 billion, a P/E ratio of 24.79, a P/E/G ratio of 2.56 and a beta of 1.13. The company has a current ratio of 0.76, a quick ratio of 0.72 and a debt-to-equity ratio of 5.01. The stock has a 50-day moving average price of $23.69 and a 200 day moving average price of $25.94.
Analyst Ratings Changes
Several analysts recently commented on the stock. Benchmark restated a “buy” rating on shares of Cinemark in a report on Thursday, January 15th. B. Riley Financial decreased their target price on shares of Cinemark from $35.00 to $29.00 and set a “neutral” rating for the company in a research note on Thursday, January 22nd. Morgan Stanley restated an “equal weight” rating and set a $28.00 price target (down from $35.00) on shares of Cinemark in a report on Thursday, December 18th. Moffett Nathanson upgraded Cinemark from a “neutral” rating to a “buy” rating and set a $30.00 price objective for the company in a report on Tuesday, January 20th. Finally, Roth Mkm reissued a “buy” rating and set a $35.00 price objective on shares of Cinemark in a research report on Wednesday, November 5th. Ten analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $32.83.
Insider Transactions at Cinemark
In related news, EVP Melissa Thomas sold 22,082 shares of Cinemark stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $24.81, for a total value of $547,854.42. Following the transaction, the executive vice president owned 167,360 shares in the company, valued at $4,152,201.60. This trade represents a 11.66% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 2.30% of the company’s stock.
Hedge Funds Weigh In On Cinemark
Several large investors have recently bought and sold shares of CNK. EverSource Wealth Advisors LLC raised its holdings in Cinemark by 118.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 935 shares of the company’s stock valued at $28,000 after acquiring an additional 507 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in Cinemark by 48.0% during the second quarter. Russell Investments Group Ltd. now owns 5,228 shares of the company’s stock worth $158,000 after buying an additional 1,696 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Cinemark by 1.8% in the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 112,962 shares of the company’s stock valued at $3,113,000 after buying an additional 1,953 shares during the period. PharVision Advisers LLC raised its stake in shares of Cinemark by 19.8% in the 3rd quarter. PharVision Advisers LLC now owns 13,837 shares of the company’s stock valued at $388,000 after buying an additional 2,285 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Cinemark by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 65,699 shares of the company’s stock worth $1,635,000 after acquiring an additional 2,872 shares during the period.
Cinemark Company Profile
Cinemark Holdings, Inc (NYSE: CNK) is a leading theatrical exhibitor that acquires, develops and operates motion picture theatres under the Cinemark® brand in the United States and Latin America. The company’s core business involves the presentation of first-run feature films coupled with an array of in‐theatre services, including concessions, premium auditoriums and loyalty programs. Cinemark’s exhibition portfolio encompasses both corporate‐owned and franchised complexes, offering moviegoers a range of experiences from standard screens to large‐format halls.
The company’s product offerings extend beyond ticket sales to include an assortment of concession items, such as popcorn, fountain beverages, candy and specialty snacks, as well as bar and lounge concepts in select locations.
Further Reading
- Five stocks we like better than Cinemark
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- The day the gold market broke
Receive News & Ratings for Cinemark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cinemark and related companies with MarketBeat.com's FREE daily email newsletter.
